Business profile not generated.
Run python -m application.cli.business_profile run --market US --one SNSE, then regenerate the site.
Issue 000 | U.S. Pilot | US
SNSE
Sensei Biotherapeutics, Inc.
Passing
Verified
10-Q | 2026-05-15
Filing currency: USD
Margin of Safety
83.6%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 204,232,000USD
- Total Liabilities
- 14,191,000USD
- NCAV
- 190,041,000USD
- Cash
- 152,325,000USD
- NCAV per share
- 141.79USD/share
- Evidence
- 6 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -22,288,000 | -32,614,000 | -37,064,000 | -50,188,000 | -37,482,000 | -19,451,000 |
| Net Income | -21,085,000 | -30,157,000 | -34,101,000 | -48,588,000 | -36,794,000 | -20,100,000 |
| Cash From Operations | -20,453,000 | -24,670,000 | -32,023,000 | -39,026,000 | -30,259,000 | -17,705,000 |
| Capex | -16,000 | -146,000 | -180,000 | -321,000 | -2,026,000 | -1,206,000 |
| Free Cash Flow | -20,469,000 | -24,816,000 | -32,203,000 | -39,347,000 | -32,285,000 | -18,911,000 |
| Cash And Equivalents | 8,668,000 | 9,994,000 | 13,011,000 | 17,795,000 | 7,159,000 | 16,596,000 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 21,507,000 | 41,929,000 | 67,250,000 | 108,589,000 | 148,542,000 | 20,076,000 |
| Total Assets | 22,902,000 | 45,361,000 | 74,374,000 | 118,375,000 | 153,225,000 | 21,428,000 |
| Total Current Liabilities | 4,251,000 | 5,448,000 | 5,643,000 | 9,066,000 | 4,889,000 | 4,830,000 |
| Total Liabilities | 4,310,000 | 6,975,000 | 9,479,000 | 14,968,000 | 6,712,000 | 5,535,000 |
| Shareholders Equity | 18,592,000 | 38,386,000 | 64,895,000 | 103,407,000 | 146,513,000 | -56,443,000 |
| Shares Outstanding | 1,261,685 | 25,180,583 | 25,030,188 | 30,764,160 | 30,609,029 | 1,875,422 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 1,260,772 | 25,117,238 | 27,952,857 | 30,703,295 | 27,710,686 | n/a |
| Weighted Avg Shares Basic | 1,260,772 | 25,117,238 | 27,952,857 | 30,703,295 | 27,710,686 | n/a |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -170,627,000 | -4,957,000 | -4,851,000 | -5,206,000 | -7,274,000 | -8,274,000 | -7,823,000 | -7,787,000 | -8,730,000 | -8,142,000 | -7,737,000 | -10,177,000 | -11,008,000 | -13,048,000 | -13,941,000 | -10,712,000 | -12,487,000 | -9,413,000 | -10,316,000 | -9,784,000 |
| Net Income | -170,236,000 | -4,717,000 | -4,568,000 | -4,936,000 | -6,864,000 | -7,770,000 | -7,253,000 | -7,142,000 | -7,992,000 | -7,414,000 | -7,124,000 | -9,386,000 | -10,177,000 | -12,232,000 | -13,416,000 | -10,535,000 | -12,405,000 | -9,366,000 | -9,685,000 | -9,771,000 |
| Cash From Operations | -10,733,000 | -3,864,000 | -3,586,000 | -5,909,000 | -7,094,000 | -5,792,000 | -5,470,000 | -5,792,000 | -7,616,000 | -6,163,000 | -4,661,000 | -9,463,000 | -11,736,000 | -9,574,000 | -6,803,000 | -11,899,000 | -10,750,000 | -7,868,000 | -5,577,000 | -6,047,000 |
| Capex | -6,000 | 0 | 0 | -16,000 | 0 | 0 | 0 | -109,000 | -37,000 | 0 | 0 | -29,000 | -151,000 | 0 | -250,000 | -52,000 | -19,000 | -535,000 | -388,000 | -616,000 |
| Free Cash Flow | -10,739,000 | -3,864,000 | -3,586,000 | -5,925,000 | -7,094,000 | -5,792,000 | -5,470,000 | -5,901,000 | -7,653,000 | -6,163,000 | -4,661,000 | -9,492,000 | -11,887,000 | -9,574,000 | -7,053,000 | -11,951,000 | -10,769,000 | -8,403,000 | -5,965,000 | -6,663,000 |
| Cash And Equivalents | 152,325,000 | 8,668,000 | 10,562,000 | 12,557,000 | 9,877,000 | 9,994,000 | 19,131,000 | 11,891,000 | 10,956,000 | 13,011,000 | 11,343,000 | 10,226,000 | 8,109,000 | 17,795,000 | 11,450,000 | 9,899,000 | 8,721,000 | 7,159,000 | 9,533,000 | 15,599,000 |
| Total Current Assets | 204,232,000 | 21,507,000 | 25,785,000 | 29,572,000 | 35,682,000 | 41,929,000 | 48,098,000 | 53,944,000 | 60,234,000 | 67,250,000 | 73,836,000 | 81,069,000 | 98,608,000 | 108,589,000 | 118,482,000 | 127,491,000 | 138,977,000 | 148,542,000 | 158,162,000 | 165,613,000 |
| Total Liabilities | 14,191,000 | 4,310,000 | 4,582,000 | 4,469,000 | 6,286,000 | 6,975,000 | 7,475,000 | 7,607,000 | 8,221,000 | 9,479,000 | 10,658,000 | 10,379,000 | 13,083,000 | 14,968,000 | 14,817,000 | 12,120,000 | 14,730,000 | 6,712,000 | 6,041,000 | 4,599,000 |
| Shares Outstanding | 1,340,333 | 1,261,685 | 1,261,290 | 1,261,290 | 25,208,068 | 25,180,583 | 25,151,379 | 25,124,333 | 25,073,958 | 25,030,188 | 24,996,517 | 26,583,819 | 30,971,341 | 30,764,160 | 30,720,921 | 30,720,921 | 30,682,813 | 30,609,029 | 30,588,495 | 30,588,495 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 1,295,052 | 1,260,772 | 1,261,290 | 1,260,867 | 25,192,363 | 25,117,238 | 25,147,999 | 25,104,439 | 25,049,111 | 27,952,857 | 28,942,803 | 30,685,561 | 30,866,087 | 30,703,295 | 30,720,291 | 30,701,758 | 30,647,679 | 27,710,686 | 30,588,495 | n/a |
| Weighted Avg Shares Basic | 1,295,052 | 1,260,772 | 1,261,290 | 1,260,867 | 25,192,363 | 25,117,238 | 25,147,999 | 25,104,439 | 25,049,111 | 27,952,857 | 28,942,803 | 30,685,561 | 30,866,087 | 30,703,295 | 30,720,291 | 30,701,758 | 30,647,679 | 27,710,686 | 30,588,495 | n/a |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 204,232,000USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001829802/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json |
| Total Liabilities | 14,191,000USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001829802/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json |
| Cash | 152,325,000USD | us-gaap:CashAndCashEquivalentsAtCarryingValue | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001829802/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json |
| Shares Outstanding | 1,340,333 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001829802/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json |
| NCAV | 190,041,000USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 141.79USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 83.6% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- D:\Projects\The Data Vault
- CIK
- 0001829802
- Company ID
- n/a
- Selected Annual Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json
- Selected Quarterly Source
- D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001829802\companyfacts.json
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 21
- Imported At
- 2026-07-04T23:04:38+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001193125-26-225333
- CIK
- 0001829802
- Mary Filing Date
- 2026-05-15
- Filing Currency
- USD
- Internal Discount
- 83.6%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-15; mary_accession=0001193125-26-225333; mary_cik=0001829802; gnni_supporting_filing_date=2026-05-15; internal_discount=0.835668; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.